What ASCO’s first ctDNA guideline means for lymphoma
ASCO’s first guideline on ctDNA testing in solid tumors and lymphoma was published by Christina Lockwood, PhD, head of the Genetics and Solid
Lymphoma
Aggressive B-Cell Lymphomas
News
Meetings / Conferences
EHA 2026
ASCO 2026
Myeloproliferative Neoplasms
Patients with myelofibrosis and anemia respond to antihemojuvelin drug
The investigational drug blocks the expression of HJV in order to reduce hepcidin. It is in mid-stage development by Disc Medicine. Updated data
Acute Myeloid Leukemia
ASCO 2026
News
Which AML patients get lasting benefit from olutasidenib?
In an analysis presented at ASCO 2026, Justin Watts, MD, of the University of Miami and colleagues explored what baseline factors — including
Cellular Therapy
ASCO 2026
News
Data support COVID-19 vaccination in patients receiving CAR-T therapy
There have been concerns about whether vaccines work well in patients who have received CAR-T therapy and whether vaccination would increase the risk